Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Expert Review of Gastroenterology & Hepatology|April 21, 2021
Gallbladder carcinosarcoma: current perspectives and new developmentXiaorong Chen, Yuwen Zhou, Xinyao Shu, et al.Chinese Clinical Oncology|January 14, 2025
E203K mutation in MAP2K1 (MEK1) causes acquired resistance to PD-1 blockade but responds to trametinib: a case reportWeibing Leng, Guixia Wei, Leiming Sheng, et al.Clinical Medicine Insights. Oncology|February 14, 2022
Cervical Carcinosarcoma: Current Understanding on Pathogenesis, Diagnosis, Management and Future PerspectivesXinyao Shu, Yuwen Zhou, Guixia Wei, et al.Frontiers in Oncology|October 4, 2021
Intra-Abdominal Desmoplastic Small Round Cell Tumor: Current Treatment Options and PerspectivesGuixia Wei, Xinyao Shu, Yuwen Zhou, et al.Clinical Medicine Insights. Oncology|March 31, 2022
Impact of Upfront Chemotherapy on the Effect of Primary Tumour Resection for Asymptomatic Synchronous Colorectal Cancer With Unresectable Metastases: A Propensity-Score-Matched Cohort AnalysisLin Huang, Guixia Wei, Nan Chen, et al.Frontiers in Oncology|May 19, 2022
Clinical Characteristics and Outcome Between Gallbladder Squamous Cell Carcinoma and Adenocarcinoma: A Propensity Matched Analysis Based on the Surveillance, Epidemiology, and End Results DatabaseXiaorong Chen, Yuwen Zhou, Qian Xu, et al.Frontiers in Immunology|October 18, 2021
Case Report: Immune and Genomic Characteristics Associated With Hyperprogression in a Patient With Metastatic Deficient Mismatch Repair Gastrointestinal Cancer Treated With Anti-PD-1 AntibodyWenyue Zhou, Yuwen Zhou, Cheng Yi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2026
An on-site cascading vaccine breaks tumor immune evasion and elicits systemic immunityXianzhou Huang, Lu Li, Shuzhen Zheng, et al.Pageof 1